Nyxoah SA NYXH 深 沪
已收盘 07-02 16:00:00 美东时间
1.72
-0.060
-3.37%
华盛通- 最 高1.80
- 今 开1.74
- 成交量 11.06万股
- 最 低 1.665
- 昨 收 1.78
- 总市值 1.72亿
- 52周最高 8.5878
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 1.26
- 委 比 14.64%
- 总股本 9992.63万
- 历史最高 37.00
- 量 比 0.91
- 振 幅 7.58%
- 历史最低 1.26
- 每 手 1
- 风险率 1.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
Nyxoah Receives $15M Second Tranche Proceeds From Its Loan Facility With European Investment Bank
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that it has received $15 million (€13.8 million) in proceeds from the second tranche of its loan facility...
06-18 04:06
Stifel Maintains Hold on Nyxoah, Lowers Price Target to $3
Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Hold and lowers the price target from $5 to $3.
06-18 01:14
Nyxoah Receives $15 Million from the European Investment Bank
Nyxoah has received $15 million from the European Investment Bank, bringing its total capital raised in June 2026 to $110 million. The funds will accelerate the commercial launch of its Genio system in the U.S., support R&D, and expand manufacturing. Genio, a hypoglossal neurostimulation therapy for Obstructive Sleep Apnea, has received CE and FDA approvals. This non-dilutive financing strengthens Nyxoah's balance sheet, enabling growth and innov...
06-17 20:05
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
Nyxoah's Genio® system has won the Prix Galien UK 2026 Award for Best Medical Technology, recognizing its innovative hypoglossal nerve stimulation therapy for Obstructive Sleep Apnea (OSA). The award highlights Genio's contribution to improving patient care and outcomes for this chronic condition, which affects millions worldwide. Nyxoah CEO Olivier Taelman emphasized the collective effort behind the achievement, acknowledging engineers, healthca...
06-15 20:05
What's Going On With Nyxoah Stock Tuesday?
Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&D. Stock ticks up in premarket.
06-09 21:04
Nyxoah Announces Underwritten Public Offering Of $95M Through Sale Of 55,232,558 Shares At A Price Of $1.72/Share
Nyxoah Announces Pricing of $95 Million Underwritten Public OfferingMont-Saint-Guibert, Belgium – June 5, 2026, 5:25 pm CET / 11:25 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a
06-05 23:31
BUZZ-Medical device co Nyxoah plunges on stock offering
BUZZ-Medical device co Nyxoah plunges on stock offering ** U.S.-listed shares of Belgian medical device maker Nyxoah SA NYXH.O plunge 50% to record low $1.44 early Fri as it looks to raise equity ** Co focused on obstructive sleep apnea solutions late Thurs commenced stock offering ** It intends to
06-05 22:04
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Bio Green Med Solution (NASDAQ:BGMS) stock increased by 180.2% to $2.9...
06-05 20:05
Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket
Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing their extreme-climate battery technology.
06-05 18:03
